Work

Real-world utilization of bispecific antibodies for treatment of diffuse large B-cell lymphoma (DLBCL) in the US community oncology setting

Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417008250
Cites:
Cited by:
Related to: